PPA2 and prostate carcinoma: Protein network analysis and clustering of differentially expressed proteins revealed new targets such as DDAH1, ARG2, EIF4A3, Par4, PPA2, Prdx3 and Prdx4, which need further validation to define their potential application in clinical relevance in prostate cancer.